| Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards S Vasikaran, R Eastell, O Bruyère, AJ Foldes, P Garnero, A Griesmacher, ... Osteoporosis international 22, 391-420, 2011 | 1215 | 2011 |
| The assessment of vertebral deformity: a method for use in population studies and clinical trials EV McCloskey, TD Spector, KS Eyres, ED Fern, N O'rourke, S Vasikaran, ... Osteoporosis International 3, 138-147, 1993 | 579 | 1993 |
| International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis S Vasikaran, C Cooper, R Eastell, A Griesmacher, HA Morris, T Trenti, ... Clinical Chemistry and Laboratory Medicine (CCLM) 49 (8), 1271-1274, 2011 | 395 | 2011 |
| Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis SA Khan, JA Kanis, S Vasikaran, WF Kline, BK Matuszewski, ... Journal of Bone and Mineral Research 12 (10), 1700-1707, 1997 | 331 | 1997 |
| B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo … Hankey GJ, Eikelboom JW, Baker RI, Gelavis A, Hickling SC, Jamrozik K, van ... Lancet Neurol 9, 855-865, 2010 | 303* | 2010 |
| Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis J Lee, S Vasikaran Annals of laboratory medicine 32 (2), 105-112, 2012 | 298* | 2012 |
| Methylenetetrahydrofolate reductase gene and coronary artery disease FM van Bockxmeer, CDS Mamotte, SD Vasikaran, RR Taylor Circulation 95 (1), 21-23, 1997 | 238 | 1997 |
| Clinical utility and measurement of procalcitonin I Samsudin, SD Vasikaran The Clinical Biochemist Reviews 38 (2), 59, 2017 | 196 | 2017 |
| Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir D Nolan, R Upton, E McKinnon, M John, I James, B Adler, G Roff, ... Aids 15 (10), 1275-1280, 2001 | 194 | 2001 |
| A meta-analysis of reference markers of bone turnover for prediction of fracture H Johansson, A Odén, JA Kanis, EV McCloskey, HA Morris, C Cooper, ... Calcified tissue international 94, 560-567, 2014 | 190 | 2014 |
| Bisphosphonates: an overview with special reference to alendronate SD Vasikaran Annals of clinical biochemistry 38 (6), 608-623, 2001 | 156 | 2001 |
| Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and … P Glendenning, M Taranto, JM Noble, AA Musk, C Hammond, ... Annals of clinical biochemistry 43 (1), 23-30, 2006 | 150 | 2006 |
| A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life OP Almeida, NT Lautenschlager, S Vasikaran, P Leedman, A Gelavis, ... Neurobiology of aging 27 (1), 141-149, 2006 | 145 | 2006 |
| Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis SD Vasikaran Critical reviews in clinical laboratory sciences 45 (2), 221-258, 2008 | 130 | 2008 |
| Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life OP Almeida, L Flicker, NT Lautenschlager, P Leedman, S Vasikaran, ... Neurobiology of aging 26 (2), 251-257, 2005 | 127 | 2005 |
| Association of cardiovascular risk factors and disease with depression in later life OP Almeida, L Flicker, P Norman, GJ Hankey, S Vasikaran, ... The American Journal of Geriatric Psychiatry 15 (6), 506-513, 2007 | 123 | 2007 |
| Clinical usefulness of bone turnover marker concentrations in osteoporosis HA Morris, R Eastell, NR Jorgensen, E Cavalier, S Vasikaran, SAP Chubb, ... Clinica chimica acta 467, 34-41, 2017 | 119 | 2017 |
| A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone JP Walsh, LC Ward, GO Stewart, RK Will, RA Criddle, RL Prince, ... Bone 34 (4), 747-754, 2004 | 118 | 2004 |
| A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement H Blain, T Masud, P Dargent-Molina, FC Martin, E Rosendahl, ... The journal of nutrition, health & aging 20, 647-652, 2016 | 115 | 2016 |
| Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia NT Lautenschlager, L Flicker, S Vasikaran, P Leedman, OP Almeida The American Journal of Geriatric Psychiatry 13 (8), 731-734, 2005 | 115 | 2005 |
Howard A. MorrisProfessor of Medical Sciences, University of South AustraliaVerified email at HEALTH.SA.GOV.AU
